| | Disease | Statistics | Median (Q1, Q3) | Logged: median (Q1, Q3) |
| | All (N = 368) | Relative effect size | 1.89 (1.41, 2.95) | 0.64 (0.35, 1.08) | | Standard error | 0.63 (0.22, 2.28) | 0.27 (0.13, 0.49) | | E-value | 3.19 (2.18, 5.35) | 1.16 (0.78, 1.68) | | E-value for the 95% CI lower bound | 1.77 (1.31, 2.71) | 0.57 (0.27, 1.00) |
| | Infections and infestations (N = 80) | Relative effect size | 2.18 (1.64, 2.88) | 0.78 (0.50, 1.06) | | Standard error | 1.31 (0.44, 3.86) | 0.38 (0.21, 0.61) | | E-value | 3.78 (2.67, 5.20) | 1.33 (0.98, 1.65) | | E-value for the 95% CI lower bound | 1.69 (1.28, 2.68) | 0.52 (0.25, 0.98) |
| | Cardiac disorders (N = 51) | Relative effect size | 1.54 (1.30, 1.93) | 0.43 (0.27, 0.66) | | Standard error | 0.31 (0.14, 0.59) | 0.15 (0.10, 0.26) | | E-value | 2.45 (1.93, 3.27) | 0.90 (0.66, 1.18) | | E-value for the 95% CI lower bound | 1.54 (1.22, 2.08) | 0.43 (0.20, 0.73) |
| | Neoplasms benign, malignant and unspecified (incl cysts and polyps) (N = 26) | Relative effect size | 1.85 (1.58, 2.59) | 0.61 (0.46, 0.95) | | Standard error | 0.59 (0.30, 2.19) | 0.29 (0.15, 0.49) | | E-value | 3.10 (2.54, 4.63) | 1.13 (0.93, 1.53) | | E-value for the 95% CI lower bound | 2.06 (1.56, 3.25) | 0.72 (0.45, 1.17) |
|
|
CI, confidence interval on the effect size. Note that, for consistency, we inverted effect size was necessary so that all effects were greater than 1. Here, for logged standard error (LSE), we use the equation LSE = (Ln(UB)-Ln(LB))/3.92, where UB and LB are upper and lower bounds of 95% CI.
|
